Macrophage Covalent Immune Recruiters (mCIRs): A novel synthetic immunotherapeutic enforcing tumor immune recognition
Macrophage Covalent Immune Recruiters (mCIRs): A novel synthetic immunotherapeutic enforcing tumor immune recognition
巨噬细胞共价免疫招募剂（mCIR）：一种新型合成免疫治疗剂，可增强肿瘤免疫识别
批准号：
458594
负责人：
Kapcan Eden
金额：
$7.65万
依托单位：
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-11-01 至 2024-11-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The immune system is trained at recognizing and killing dangerous objects in your body. These dangerous objects could be bacteria, viruses, or cancer. Sometimes cancer is able to evade the immune system, allowing it to grow and become dangerous.
Scientis
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of “Covalent Antibody Recruiting Molecules” Tumor Immunotherapeutics
-
批准号：449819
-
项目类别：Studentship Programs
-
资助金额：$1.27万
-
财政年份：2020
-
负责人：Kapcan Eden
-
依托单位：
海外基金
